Dermavon Holdings Limited
Clinical trials sponsored by Dermavon Holdings Limited, explained in plain language.
-
New psoriasis pill aims for clearer skin in major trial
Disease control Not yet recruitingThis study is testing whether a new pill called CMS-D001 can help adults with moderate to severe plaque psoriasis. Researchers will compare the pill to a placebo (a dummy pill) in about 540 participants to see if it safely reduces the severity of skin plaques and improves quality…
Phase: PHASE2, PHASE3 • Sponsor: Dermavon Holdings Limited • Aim: Disease control
Last updated Apr 02, 2026 02:26 UTC
-
New drug tested for stubborn eczema that resists creams
Disease control Not yet recruitingThis study is testing an experimental oral medication called CMS-D001 for adults with moderate to severe eczema (atopic dermatitis) that hasn't responded well to standard creams. About 160 participants will be randomly assigned to receive one of three different doses of the drug …
Phase: PHASE2 • Sponsor: Dermavon Holdings Limited • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC